Gewählte Publikation:
Porta, S; Himly, C; Rinner, I; Schwarz, U; Werner, M; Poncza, B; Korsatko, W.
Isoprenaline cannot act on pancreatic beta cells without hyperglycemia or alpha-block.
EXP PATHOL. 1991; 43(1-2): 57-61.
Doi: 10.1016/S0232-1513(11)80144-1
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Porta Sepp
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- During long-term increase in isoprenaline (pronounced beta-effect) and isoprenaline plus regitine (pure beta-effect) pancreatic insulin-secretion still depended mostly on blood glucose levels. This means that increased beta-effect during normo- or hypoglycemia could not cause a higher insulin-secretion. Only during additional alpha-receptor blockade insulin-secretion was slightly but insufficiently increased. Catecholamines seem to be more regulator than originator of the insulin secretory process.
- Find related publications in this database (using NLM MeSH Indexing)
-
Animals -
-
Blood Glucose - metabolism
-
Epinephrine - blood
-
Insulin - blood
-
Islets of Langerhans - drug effects
-
Isoproterenol - blood
-
Male - blood
-
Norepinephrine - blood
-
Pancreas - metabolism
-
Phentolamine - blood
-
Rats - blood
-
Rats, Inbred Strains - blood
-
Receptors, Adrenergic, alpha - drug effects
- Find related publications in this database (Keywords)
-
Isoprenaline
-
Pancreatic Beta-Cells
-
Hyperglycemia
-
Alpha-Receptor Blockade
-
Regitine
-
Insulin Secretion
-
Receptor Blockade
-
Alpha
-
Catecholamines
-
Beta-Cells
-
Pancreatic
-
Hypoglycemia
-
Glucose
-
Blood
-
Blood Glucose